Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹1,047 Cr₹-1,502 Cr₹297 Cr₹942 Cr₹970 Cr

What is the latest Consolidated Net Profit of GLENMARK PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of GLENMARK PHARMACEUTICALS is ₹1,047 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹1,047 Cr
Mar2025₹-1,502 Cr
Mar2024₹297 Cr
Mar2023₹942 Cr
Mar2022₹970 Cr

How is Consolidated Net Profit of GLENMARK PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹1,047 Cr
Positive
Mar2025 ₹-1,502 Cr
Negative
Mar2024 ₹297 Cr
-68.44
Mar2023 ₹942 Cr
-2.92
Mar2022 ₹970 Cr -

Compare Consolidated Net Profit of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹65,611.5 Cr -0.6% 5.8% 11% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr -1.2% -2.2% 15.8% Stock Analytics
DIVIS LABORATORIES ₹227,958.0 Cr 1% 16.3% 39.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,990.0 Cr 3.2% -0.8% 38.6% Stock Analytics
CIPLA ₹116,141.0 Cr -0.9% 1.6% -9.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,604.4 Cr -1.7% -0.1% -6.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.6%

5.8%

11%

SENSEX

-0.7%

0.1%

-3.4%


You may also like the below Video Courses